Diagnostics & prognostics

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives

Could changes in retinal blood vessels act as an early bio-marker for Alzheimer’s disease?

Could a multi-layer graphene (MLG)-based biomarker sensor offer the sensitivity needed for earlier lung cancer detection?